The Centers for Medicare & Medicaid Services (CMS) has assigned a permanent J-code for TECENTRIQ® (atezolizumab).
The permanent J-code for TECENTRIQ is J9022 (injection, atezolizumab, 10 mg). The J-code goes into effect on January 1, 2018. Please check with your payers to verify codes and special billing requirements. Also, please be sure to prepare your systems as appropriate for the introduction of this new permanent J-code.
Please contact Genentech Access Solutions for TECENTRIQ at (888) 249-4918 Monday through Friday, 6 a.m.-5 p.m. PT, or visit Genentech-Access.com/TECENTRIQ for more information.
